Dombivli, India

Shrikant V Rao

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shrikant V Rao. Retrieved from https://idiyas.com/inventor/shrikant-v-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Shrikant V Rao

Introduction: Shrikant V Rao is an accomplished inventor based in Dombivili (West), India, recognized for his contributions to the field of medicinal chemistry. His work focuses on developing compounds to treat chronic health conditions, particularly arthritis and rheumatism.

Latest Patents: Shrikant V Rao holds a patent for a unique compound: 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl))piperidinyl]-4H-1-benzopyran-4-one. This invention pertains to its preparation and application, showcasing its efficacy in treating chronic inflammatory diseases, enhancing the quality of life for many individuals suffering from these ailments.

Career Highlights: Currently, Shrikant is associated with Hoechst Aktiengesellschaft, a renowned company that specializes in pharmaceuticals and biotechnology. His innovative approaches and deep understanding of medicinal chemistry have positioned him as a key figure in the development of new treatments.

Collaborations: Throughout his career, Shrikant has collaborated with esteemed colleagues such as Ramachandra Ganapati Naik and Aftab Dawoodbhai Lakdawala. These partnerships have facilitated a productive exchange of ideas and expertise, contributing to successful research outcomes.

Conclusion: Shrikant V Rao's dedication to innovation and his impressive patent in the field of medicinal chemistry demonstrate his commitment to advancing healthcare solutions. As he continues to work alongside other experts at Hoechst Aktiengesellschaft, the impact of his inventions promises to enhance the treatment available for chronic inflammatory diseases, offering hope for many patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…